Cargando…
Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study
Autores principales: | Arias‐Mejias, Suzette M., Quattrocchi, Enrica, Tempel, Dennie, Luna‐Vargas, Mark, Chen, Jeff, Murphree, Dennis H., Gjorgova Gjeorgjievski, Sandra, Lehman, Julia S., Bridges, Alina G., Dwarkasing, Jvalini, Meves, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687092/ https://www.ncbi.nlm.nih.gov/pubmed/32516450 http://dx.doi.org/10.1111/ijd.14987 |
Ejemplares similares
-
Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
por: Bellomo, Domenico, et al.
Publicado: (2020) -
Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study
por: Hieken, Tina J., et al.
Publicado: (2022) -
Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study
por: Yousaf, Ahmed, et al.
Publicado: (2021) -
Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis
por: Thao, Viengneesee, et al.
Publicado: (2022) -
“Transforming the Beast to A Beauty”- Fifteen Years into the Making - Case Report of Congenital Neurofibromatosis
por: Tudzarova-Gjorgova, Smilja, et al.
Publicado: (2019)